Compumedics (ASX:CMP) is expected to book fiscal first-half sales orders of more than AU$31 million, driven by an over 200% jump in US sales orders year on year, according to a Monday filing with the Australian bourse.

The company forecasts revenue of AU$55 million for the fiscal year ending June 30, 2025, while the outlook of earnings before interest, taxes, depreciation, and amortization of AU$5 million will be weighted to the second half of the year, the filing said.

The medical company said its guidance for the fiscal year will be reviewed after the first half results are finalized.

Its shares rose 2% at market close.